Physician profile
Brittain E Jenson
NPI 1417653411
$657.43
in general payments reported to CMS, 2019-2025
12 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $254 · 2024: $192 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.93 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $107.76 | 2023-2025 | Spravato |
| Boston Scientific Corporation | $59.70 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $57.44 | 2023-2024 | Mounjaro |
| Organon LLC | $47.01 | 2025 | Nexplanon |
| Pfizer INC. | $36.05 | 2023 | |
| Novo Nordisk INC | $33.93 | 2023-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $31.24 | 2025 | Airsupra |
| Phathom Pharmaceuticals, INC. | $29.83 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.09 | 2023 | Jardiance |
| Medtronic, INC. | $14.42 | 2023 | Minimed 780g |
| Inspire Medical Systems, INC. | $14.03 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittain Jenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.